Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Ironwood announce linaclotide collaboration for China
-
AstraZeneca and Ardelyx announce worldwide licensing deal for NHE3 inhibitor programme for complications of renal disease, including diabetes-induced renal disease
-
AstraZeneca suspends share repurchase programme, Core EPS target in the range of $6.00 and $6.30 unchanged
-
AstraZeneca prices a $2 billion bond issue
-
Pascal Soriot appointed Chief Executive Officer of AstraZeneca
-
European Commission approves ZINFORO™ (ceftaroline fosamil) for adult patients with serious skin infections or community acquired pneumonia
-
AstraZeneca and Pfizer enter agreement for over-the-counter NEXIUM; AstraZeneca raises 2012 guidance
-
AstraZeneca and Bristol-Myers Squibb complete expansion of diabetes alliance through Bristol-Myers Squibb’s acquisition of Amylin Pharmaceuticals
-
AstraZeneca PLC Second quarter and half year results 2012
-
AstraZeneca reports terms of David Brennan’s retirement
Latest articles and press releases
All of our latest press releases and articles are available to explore
